10-15 Associates Inc increased Merck & Co Inc (MRK) stake by 17.12% reported in 2017Q3 SEC filing. 10-15 Associates Inc acquired 19,275 shares as Merck & Co Inc (MRK)’s stock declined 2.46%. The 10-15 Associates Inc holds 131,885 shares with $8.44M value, up from 112,610 last quarter. Merck & Co Inc now has $148.67 billion valuation. The stock increased 0.04% or $0.02 during the last trading session, reaching $54.57. About 10.82 million shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since February 23, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.
Analysts expect Triple-S Management Corporation (NYSE:GTS) to report $0.27 EPS on March, 1 before the open.They anticipate $0.13 EPS change or 92.86% from last quarter’s $0.14 EPS. GTS’s profit would be $6.37 million giving it 23.46 P/E if the $0.27 EPS is correct. After having $0.77 EPS previously, Triple-S Management Corporation’s analysts see -64.94% EPS growth. The stock decreased 0.08% or $0.02 during the last trading session, reaching $25.34. About 161,225 shares traded or 31.90% up from the average. Triple-S Management Corporation (NYSE:GTS) has declined 25.70% since February 23, 2017 and is downtrending. It has underperformed by 42.40% the S&P500.
Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 17 have Buy rating, 0 Sell and 7 Hold. Therefore 71% are positive. Merck & Co. Inc. had 79 analyst reports since August 13, 2015 according to SRatingsIntel. The stock has “Outperform” rating by Credit Suisse on Wednesday, February 14. The stock of Merck & Co., Inc. (NYSE:MRK) has “Buy” rating given on Friday, August 19 by UBS. The firm earned “Outperform” rating on Thursday, October 12 by BMO Capital Markets. The stock of Merck & Co., Inc. (NYSE:MRK) has “Sell” rating given on Thursday, May 25 by Jefferies. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) on Friday, August 18 with “Sell” rating. Citigroup upgraded Merck & Co., Inc. (NYSE:MRK) on Wednesday, October 18 to “Buy” rating. On Tuesday, February 6 the stock rating was maintained by Leerink Swann with “Market Perform”. The firm has “Buy” rating by Piper Jaffray given on Friday, July 28. BMO Capital Markets maintained Merck & Co., Inc. (NYSE:MRK) rating on Friday, July 28. BMO Capital Markets has “Buy” rating and $7300 target. The firm has “Buy” rating given on Wednesday, July 19 by BMO Capital Markets.
Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.01, from 1.07 in 2017Q2. It is negative, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Smead Capital Mngmt invested 3.44% in Merck & Co., Inc. (NYSE:MRK). Dynamic Advisors Solutions Ltd Liability Co has 0.21% invested in Merck & Co., Inc. (NYSE:MRK) for 8,119 shares. Cubist Systematic Strategies Ltd Liability invested 0.22% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Moreover, Strategy Asset Managers Llc has 2.05% invested in Merck & Co., Inc. (NYSE:MRK). Massachusetts Ma stated it has 12.44 million shares or 0.35% of all its holdings. Rice Hall James Associates Lc invested 0.02% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Texas Yale Cap Corp reported 0.26% in Merck & Co., Inc. (NYSE:MRK). Synovus Fin reported 0.52% in Merck & Co., Inc. (NYSE:MRK). Tci Wealth Advisors Inc reported 18,444 shares stake. Clarivest Asset Mgmt holds 0.01% or 5,225 shares in its portfolio. First Eagle Invest Management Ltd Liability owns 27,790 shares or 0% of their US portfolio. Intersect Cap Ltd Llc reported 60,976 shares stake. Wilkins Counsel holds 4.17% or 213,829 shares in its portfolio. Private Trust Na accumulated 58,943 shares. Trustmark Bankshares Tru Department holds 49,821 shares.
Triple-S Management Corporation, through its subsidiaries, provides a portfolio of managed care and related products in the commercial, Medicare, and Medicaid markets in Puerto Rico, the United States. The company has market cap of $597.43 million. The firm operates through three divisions: Managed Care, Life Insurance, and Property and Casualty Insurance. It has a 14.52 P/E ratio. It offers various managed care products, including health maintenance organization plans; preferred well-known provider organization plans; BlueCard program; Medicare Supplement products; Medicare Part D, a prescription drug plan; Medicare Advantage products; Medicaid plans; and claims processing and other administrative services.
Investors sentiment increased to 2.06 in Q3 2017. Its up 1.15, from 0.91 in 2017Q2. It improved, as 8 investors sold Triple-S Management Corporation shares while 25 reduced holdings. 31 funds opened positions while 37 raised stakes. 20.03 million shares or 2.77% more from 19.49 million shares in 2017Q2 were reported. Swiss Bancshares holds 40,400 shares or 0% of its portfolio. Trexquant Inv L P stated it has 21,270 shares or 0.13% of all its holdings. Massachusetts-based Bogle Inv Lp De has invested 0.15% in Triple-S Management Corporation (NYSE:GTS). Wells Fargo & Mn, a California-based fund reported 18,285 shares. Wellington Management Grp Ltd Liability Partnership holds 0% or 140,667 shares. Jacobs Levy Equity Management holds 0.04% or 88,884 shares. Acadian Asset Mgmt Ltd Limited Liability Company reported 494,701 shares or 0.05% of all its holdings. 23,917 are owned by State Board Of Administration Of Florida Retirement System. Lucus Limited Liability Company accumulated 0.51% or 15,141 shares. Lakewood Cap Ltd Partnership reported 796,498 shares. Nationwide Fund Advisors has invested 0% of its portfolio in Triple-S Management Corporation (NYSE:GTS). Metropolitan Life Ins Ny holds 0% of its portfolio in Triple-S Management Corporation (NYSE:GTS) for 16,663 shares. Macquarie Limited accumulated 13,857 shares. D E Shaw Communication invested in 462,915 shares. Legal General Gru Public Limited Co holds 0% or 6,912 shares in its portfolio.
Since September 13, 2017, it had 0 buys, and 2 sales for $32,957 activity. Diaz Juan J. sold 600 shares worth $14,400.